TuHURA Biosciences, Inc. HURA Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $6.3M+74.0% | $3.62M+34.2% | $2.7M-68.3% | $8.51M+36.9% | $6.22M-50.9% | ||
| $6.98M+51.1% | $4.62M+31.9% | $3.5M-72.1% | $12.54M-12.5% | $14.33M-27.0% | ||
| $326.01K+8.4% | $300.64K+1.8% | $295.33K+105% | $144.17K-5.1% | $151.98K+23.2% | ||
| $349.63K-9.1% | $384.53K+365% | $82.71K— | —— | —— | ||
| $10.74M— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| $29.7M+8.6% | $27.35M+6.4% | $25.7M-25.8% | $34.62M+137% | $14.64M-26.7% | ||
| $5.86M+6.1% | $5.52M+0.8% | $5.48M-54.7% | $12.09M+162% | $4.62M-10.7% | ||
| $206.85K+3.9% | $199.04K+136% | $84.35K— | —— | —— | ||
| $6.07M+2.5% | $5.92M-33.0% | $8.83M-41.8% | $15.17M+217% | $4.78M-10.3% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| $6.51M+1.5% | $6.42M-28.0% | $8.92M-41.2% | $15.17M+217% | $4.78M-11.0% | ||
| $63.58K+7.1% | $59.34K+15.8% | $51.26K+2.7% | $49.91K+14.3% | $43.68K+3.2% | ||
| $171.57M+6.1% | $161.78M+7.2% | $150.87M+3.0% | $146.44M+12.3% | $130.38M+4.0% | ||
| -$148.72M-5.3% | -$141.18M-5.0% | -$134.42M-5.6% | -$127.32M-8.1% | -$117.79M-6.0% | ||
| $23.19M+10.8% | $20.93M+24.8% | $16.78M-13.7% | $19.45M+97.3% | $9.86M-32.5% | ||
| $29.7M+8.6% | $27.35M+6.4% | $25.7M-25.8% | $34.62M+137% | $14.64M-26.7% | ||
| $684.16K+36.5% | $501.19K-37.9% | $806.43K— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| $349.63K-9.1% | $384.53K+365% | $82.71K— | —— | —— | ||
| $11.28M— | —— | —— | —— | —— | ||
| $349.63K-9.1% | $384.53K+365% | $82.71K— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| $349.63K-9.1% | $384.53K+365% | $82.71K— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| $5.86M+6.1% | $5.52M+0.8% | $5.48M-54.7% | $12.09M+162% | $4.62M-10.7% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| $456.93K-9.1% | $502.67K+496% | $84.35K— | —— | —— | ||
| $171.57M+6.1% | $161.78M+7.2% | $150.87M+3.0% | $146.44M+12.3% | $130.38M+4.0% | ||
| $63.58K+7.1% | $59.34K+15.8% | $51.26K+2.7% | $49.91K+14.3% | $43.68K+3.2% | ||
| —— | —— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are TuHURA Biosciences, Inc.'s total assets?
- TuHURA Biosciences, Inc. (HURA) holds $29.7M in total assets, up 102.9% year over year.
- How much debt does TuHURA Biosciences, Inc. have?
- TuHURA Biosciences, Inc. carries $456.9K in total debt against $23.2M of shareholders' equity, a debt-to-equity ratio of 0.02.
- How much cash does TuHURA Biosciences, Inc. have?
- TuHURA Biosciences, Inc. holds $6.3M in cash and equivalents.
- Can TuHURA Biosciences, Inc. cover its short-term obligations?
- Its current ratio is 1.15 — current assets exceed current liabilities.
- Where does TuHURA Biosciences, Inc.'s balance sheet data come from?
- Every line is extracted from TuHURA Biosciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.